TIMP2 and Miyoshi myopathy: found that miR-483-5p was up-regulated in MM-MSCs (bone marrow-derived mesenchymal stem cells of MM patients) and could be transferred from MM-MSCs to MM cells via exosomes to favor MM progression by targeting TIMP2 (41).